Erratum: Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV

Clifford G. Banda; Dumisile Nkosi; Elizabeth Allen; Lesley Workman; Mwayiwawo Madanitsa; Marumbo Chirwa; Mayamiko Kapulula; Sharon Muyaya; Steven Munharo; Joel Tarning; Kamija S. Phiri; Victor Mwapasa; Feiko Ter Kuile; Gary Maartens; Karen I. Barnes

doi:10.1128/aac.01562-22

Erratum: Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV

Clifford G. Banda
, Dumisile Nkosi
, Elizabeth Allen
, Lesley Workman
, Mwayiwawo Madanitsa
, Marumbo Chirwa
, Mayamiko Kapulula
, Sharon Muyaya
, Steven Munharo
, Joel Tarning
, Kamija S. Phiri
, Victor Mwapasa
, Feiko Ter Kuile
, Gary Maartens
, Karen I. Barnes

Clinical Sciences

University of Cape Town
Kamuzu University of Health Sciences
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Training and Research Unit of Excellence (TRUE)
Malawi University of Science and Technology
University of Oxford
Mahidol University

Research output: Other contribution

Abstract

Volume 66, no. 12, e00584-22, 2022, https://doi.org/10.1128/aac.00584-22. In Fig. 2 and Fig. S1, the first value on the y axis previously read as “0” instead of “1.” The corrected Fig. 2 is shown below. Additionally, revised supplemental material is included with this Erratum. There are no changes to the text or figure legend. (Figure Presented).

Original language	English
Edition	1
Volume	67
DOIs	https://doi.org/10.1128/aac.01562-22
Publication status	Published - 1 Jan 2023

Publication series

Name	Antimicrobial Agents and Chemotherapy
Publisher	American Society for Microbiology
ISSN (Print)	0066-4804

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1128/aac.01562-22

Fingerprint

Dive into the research topics of 'Erratum: Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV'. Together they form a unique fingerprint.

1 Article

Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV
Banda, C. G., Nkosi, D., Allen, E., Workman, L., Madanitsa, M., Chirwa, M., Kapulula, M., Muyaya, S., Munharo, S., Tarning, J., Phiri, K. S., Mwapasa, V., Ter Kuile, F., Maartens, G. & Barnes, K. I., 14 Nov 2022, In: Antimicrobial Agents and Chemotherapy. 66, 12, p. e0058422
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Citations (Scopus)

Cite this

Banda, C. G., Nkosi, D., Allen, E., Workman, L., Madanitsa, M., Chirwa, M., Kapulula, M., Muyaya, S., Munharo, S., Tarning, J., Phiri, K. S., Mwapasa, V., Ter Kuile, F., Maartens, G., & Barnes, K. I. (2023, Jan 1). Erratum: Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV. (1 ed.) https://doi.org/10.1128/aac.01562-22

@misc{e1ed07f7f774470390a8465a33c1f5c1,

title = "Erratum: Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV",

abstract = "Volume 66, no. 12, e00584-22, 2022, https://doi.org/10.1128/aac.00584-22. In Fig. 2 and Fig. S1, the first value on the y axis previously read as “0” instead of “1.” The corrected Fig. 2 is shown below. Additionally, revised supplemental material is included with this Erratum. There are no changes to the text or figure legend. (Figure Presented).",

author = "Banda, \{Clifford G.\} and Dumisile Nkosi and Elizabeth Allen and Lesley Workman and Mwayiwawo Madanitsa and Marumbo Chirwa and Mayamiko Kapulula and Sharon Muyaya and Steven Munharo and Joel Tarning and Phiri, \{Kamija S.\} and Victor Mwapasa and \{Ter Kuile\}, Feiko and Gary Maartens and Barnes, \{Karen I.\}",

year = "2023",

month = jan,

day = "1",

doi = "10.1128/aac.01562-22",

language = "English",

volume = "67",

series = "Antimicrobial Agents and Chemotherapy",

publisher = "American Society for Microbiology",

edition = "1",

type = "Other",

}

Banda, CG, Nkosi, D, Allen, E, Workman, L, Madanitsa, M, Chirwa, M, Kapulula, M, Muyaya, S, Munharo, S, Tarning, J, Phiri, KS, Mwapasa, V, Ter Kuile, F, Maartens, G & Barnes, KI 2023, Erratum: Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV. https://doi.org/10.1128/aac.01562-22

TY - GEN

T1 - Erratum: Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV

AU - Banda, Clifford G.

AU - Nkosi, Dumisile

AU - Allen, Elizabeth

AU - Workman, Lesley

AU - Madanitsa, Mwayiwawo

AU - Chirwa, Marumbo

AU - Kapulula, Mayamiko

AU - Muyaya, Sharon

AU - Munharo, Steven

AU - Tarning, Joel

AU - Phiri, Kamija S.

AU - Mwapasa, Victor

AU - Ter Kuile, Feiko

AU - Maartens, Gary

AU - Barnes, Karen I.

PY - 2023/1/1

Y1 - 2023/1/1

N2 - Volume 66, no. 12, e00584-22, 2022, https://doi.org/10.1128/aac.00584-22. In Fig. 2 and Fig. S1, the first value on the y axis previously read as “0” instead of “1.” The corrected Fig. 2 is shown below. Additionally, revised supplemental material is included with this Erratum. There are no changes to the text or figure legend. (Figure Presented).

AB - Volume 66, no. 12, e00584-22, 2022, https://doi.org/10.1128/aac.00584-22. In Fig. 2 and Fig. S1, the first value on the y axis previously read as “0” instead of “1.” The corrected Fig. 2 is shown below. Additionally, revised supplemental material is included with this Erratum. There are no changes to the text or figure legend. (Figure Presented).

U2 - 10.1128/aac.01562-22

DO - 10.1128/aac.01562-22

M3 - Other contribution

VL - 67

T3 - Antimicrobial Agents and Chemotherapy

ER -